March 2025

Contents

Journal scan

• Cuts in aid: up to 10 million new HIV infections and almost 3 million related deaths by 2030

• Mpox vaccine efficacy dramatically lower in people living with HIV

Special reports

• CROI 2025: BHIVA best of CROI feedback meeting

• Stopping ART safely if your clinic is closed or runs out of meds: a practical guide

• Webinar on stopping ART if your clinic is closed: practical facts on safety and risk

• Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer

Conference reports

• CROI 2025: Introduction to this year’s conference

• CROI 2025: RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission

• CROI 2025: Two bNAbs enable viral suppression off-ART in African women in the FRESH cohort

• CROI 2025: Switching to daily fixed-dose doravirine/islatravir: two randomised phase 3 studies

• CROI 2025: Tecovirimat has no benefit against mpox in STOMP study

• CROI 2025: Ensitrelvir significantly reduces risk of developing COVID-19 after household exposure

• CROI 2025: N6LS: 4-monthly injectable bNAb with monthly injectable cabotegravir

• CROI 2025: Reducing Biktarvy from daily to only once, twice or three times a week

• CROI 2025: Potential for once-yearly lenacapavir injections

• CROI 2025: Delegates send open letter to protest US cuts

• CROI 2025: Stand Up For Science rally against Trump funding freeze

Guidelines

• Summary of Australian guidelines for anal cancer screening in people living with HIV

Treatment advocacy

• HIV and vaccine denialist is proposed to head the US NIH: further alarm for global science

Future meetings

• Future meetings and webinars 2025